BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31967156)

  • 1. Application of microphysiological systems in biopharmaceutical research and development.
    Peterson NC; Mahalingaiah PK; Fullerton A; Di Piazza M
    Lab Chip; 2020 Feb; 20(4):697-708. PubMed ID: 31967156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in developing microphysiological systems for biological product assessment.
    Mansouri M; Lam J; Sung KE
    Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphysiological Systems to Assess Nonclinical Toxicity.
    Van Ness KP; Chang SY; Weber EJ; Zumpano D; Eaton DL; Kelly EJ
    Curr Protoc Toxicol; 2017 Aug; 73():14.18.1-14.18.28. PubMed ID: 28777442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
    Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
    Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.
    Ishida S
    Front Toxicol; 2021; 3():657765. PubMed ID: 35295097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.
    Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M
    CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney microphysiological models for nephrotoxicity assessment.
    Mahadeo A; Yeung CK; Himmelfarb J; Kelly EJ
    Curr Opin Toxicol; 2022 Jun; 30():. PubMed ID: 35495549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
    Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
    Kanamori T; Sugiura S; Sakai Y
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programming microphysiological systems for children's health protection.
    Knudsen TB; Klieforth B; Slikker W
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1586-1592. PubMed ID: 28658972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of Microphysiological Systems: Integrating Sensors and Real-Time Data Analysis toward Autonomous Decision-Making.
    Young AT; Rivera KR; Erb PD; Daniele MA
    ACS Sens; 2019 Jun; 4(6):1454-1464. PubMed ID: 30964652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
    Wang YI; Carmona C; Hickman JJ; Shuler ML
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.